Top News

Kythera Files For IPO

Calabasas-based KYTHERA Biopharmaceuticals, a developer of biopharmaceuticals for the aesthetic medicine market, has filed for an IPO. According to the firm's S-1 filing, Kythera is looking to raise up to $86.25M on the NASDAQ Global Market as KYTH. The firm's offering is being underwritten by J.P. Morgan, Goldman, Sachs & Co., Leerink Swann, and Lazard Capital Markets. Kythera is venture backed by Versant Ventures, ARCH Ventures, Prospect Venture Partners, JAFCO, Fidelity, among others. The firm reported a net loss of $11.1M on license income of $12.98M in 2011. Kythera's products are used for fat reduction.





Latest Headlines

Browse Issues


Keep up with all of the latest Southern California high tech news via email (it's free!)

or Cancel